Pacira BioSciences, Inc.PCRX

PCRX current price
$19.86-36.53%

Capital at risk.

1W
+2.80%
1M
+20.66%
3M
+47.22%
6M
-27.36%
1Y
-36.53%
MAX
-78.52%
About Pacira BioSciences, Inc.
Ticker
info
PCRX
Trading on
info
NASDAQ
ISIN
info
US6951271005
Industry
info
Drug Manufacturers - Specialty & Generic
Sector
info
Healthcare
CEO
info
-
Headquarters
info
5401 West Kennedy Boulevard, Tampa, FL, United States, 33609
Employees
info
711
Website
info
pacira.com
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Metrics
BasicAdvanced
Market cap
info
$939M
P/E ratio
info
-
EPS
info
-$1.93
Dividend Yield
info
0.00%
Beta
info
0.82
Forward P/E ratio
info
5.93
EBIDTA
info
$178M
Ex dividend date
info
-
Price & volume
Market cap
info
$939M
Average daily volume
info
0.8M
90-day return
info
47.22%
30-day return
info
20.66%
7-day return
info
2.80%
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
5.93
PEG ratio
info
-3.83
Trailing P/E
info
0
Price to sales
info
1.35
Price to book
info
1.25
Earnings
EPS
info
-$1.93
EPS estimate (current quarter)
info
$0.70
EPS estimate (next quarter)
info
$0.81
EBITDA
info
$178M
Revenues (TTM)
info
$695M
Revenues per share (TTM)
info
$15.01
Technicals
Beta
info
0.82
52-week High
info
$35.95
52-week Low
info
$11.16
50-day moving average
info
$17.11
200-day moving average
info
$22.05
Short ratio
info
8.62
Short %
info
15.12%
Management effectiveness
ROE (TTM)
info
11.48%
ROA (TTM)
info
4.17%
Profit margin
info
13.06%
Gross profit margin
info
$393M
Operating margin
info
13.02%
Growth
Quarterly earnings growth (YoY)
info
24.50%
Quarterly revenue growth (YoY)
info
2.80%
Share stats
Outstanding Shares
info
46.2M
Float
info
45.7M
Insiders %
info
2.15%
Institutions %
info
114.68%
Analyst Insights & forecasts
info

34% Buy

44% Hold

22% Sell

Based on information from 9 analysts.

Average price target

info
$18.13
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.89
$0.88
1.14%
Q4 • 23Beat
$0.62
$0.62
-
Q1 • 24Beat
$0.89
$0.70
27.14%
Q2 • 24Beat
$0.79
$0.70
12.86%
Q3 • 24Beat
-
-
-
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$178M
$18.9M
10.61%
Q2 • 24
$169M
$-143M
85.11%
Q3 • 24
5.31%
859.64%
902.23%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$1.65B
$768M
46.61%
Q2 • 24
$1.52B
$772M
50.74%
Q3 • 24
7.60%
0.59%
8.87%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$53.2M
$-15.2M
$25M
$51.6M
Q2 • 24
$53.9M
$-52.2M
$-2.8M
$49.8M
Q3 • 24
1.28%
242.84%
111.39%
3.52%
QoQ growth
QuarterlyAnnual
Sentiment analysis

-1.5

Neutral

+1.5

0.07

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Pacira BioSciences, Inc. share?
Collapse

Pacira BioSciences, Inc. shares are currently traded for $19.86 per share.

How many shares does Pacira BioSciences, Inc. have?
Collapse

Pacira BioSciences, Inc. currently has 46.2M shares.

Does Pacira BioSciences, Inc. pay dividends?
Collapse

No, Pacira BioSciences, Inc. doesn't pay dividends.

What is Pacira BioSciences, Inc. 52 week high?
Collapse

Pacira BioSciences, Inc. 52 week high is $35.95.

What is Pacira BioSciences, Inc. 52 week low?
Collapse

Pacira BioSciences, Inc. 52 week low is $11.16.

What is the 200-day moving average of Pacira BioSciences, Inc.?
Collapse

Pacira BioSciences, Inc. 200-day moving average is $22.05.

Who is Pacira BioSciences, Inc. CEO?
Collapse

The CEO of Pacira BioSciences, Inc. is -.

How many employees Pacira BioSciences, Inc. has?
Collapse

Pacira BioSciences, Inc. has 711 employees.

What is the market cap of Pacira BioSciences, Inc.?
Collapse

The market cap of Pacira BioSciences, Inc. is $939M.

What is the P/E of Pacira BioSciences, Inc.?
Collapse

The current P/E of Pacira BioSciences, Inc. is null.

What is the EPS of Pacira BioSciences, Inc.?
Collapse

The EPS of Pacira BioSciences, Inc. is -$1.93.

What is the PEG Ratio of Pacira BioSciences, Inc.?
Collapse

The PEG Ration of Pacira BioSciences, Inc. is -3.83.

What do analysts say about Pacira BioSciences, Inc.?
Collapse

According to the analysts Pacira BioSciences, Inc. is considered a hold.

Pacira BioSciences, Inc. news